Literature DB >> 29432549

Incidence, mortality and determinants of survival from cervical cancer in Northwest Russia: a registry-based cohort study.

Andrej M Grjibovski1,2,3, Daria Dubovichenko2, Shynar Saduakassova4, Gulmira Zhatkanbayeva4, Gulzhakhan Omarova4, Gulnar Shalgumbayeva5, Lyudmila Valkova6, Mikhail Y Valkov2,6.   

Abstract

Background: Cervical cancer is the third most common cancer among women. The evidence from Russia, however, is scarce. We studied the incidence of and mortality from cervical cancer in northwest Russia, and assessed determinants of survival among cervical cancer patients.
Methods: This registry-based historical cohort study obtained data on all primary cases of cervical cancer in the Arkhangelsk region in 2000-2014 from the Arkhangelsk Regional Cancer Registry. One- and 5-y survival was calculated using life tables. Factors associated with survival were studied using Kaplan-Meier curves and Cox regression.
Results: The incidence increased from 10.9 per 100 000 in 2000 to 20.9 per 100 000 in 2014, while mortality increased from 2.0 to 7.8 per 100 000 during the same period. One- and 5-y survival was 77.4% (95% CI 75.4 to 79.4) and 60.0% (95% CI 54.6 to 61.5), respectively. Significant inverse association was observed between survival and stage of cancer. Patients with adenocarcinoma (HR=1.6, 95% CI 1.2 to 2.2), other histological types of cancer (HR=1.8, 95% CI 1.4 to 2.4) and those with undefined histologic type (HR=3.8, 95% CI 2.5 to 5.8) had shorter survival than patients with squamous cell carcinoma. Conclusions: Incidence of and mortality from cervical cancer in northwest Russia is considerably higher than in developed countries. Increased incidence in recent years may be attributed to increased screening.

Entities:  

Mesh:

Year:  2018        PMID: 29432549     DOI: 10.1093/inthealth/ihx068

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  8 in total

1.  Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.

Authors:  Andamlak Eskale Mebratie; Nurilign Abebe Moges; Belsity Temesgen Meselu; Misganaw Fikrie Melesse
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  Silencing of KCNA1 suppresses the cervical cancer development via mitochondria damage.

Authors:  Li Liu; Yumei Chen; Qingyuan Zhang; Changzhong Li
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

3.  Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study.

Authors:  Mulugeta Wassie; Zeleke Argaw; Yosief Tsige; Mesfin Abebe; Sezer Kisa
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

4.  Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.

Authors:  Zavuga Zuberi; Alex Mremi; Jaffu O Chilongola; George Semango; Elingarami Sauli
Journal:  PLoS One       Date:  2021-10-27       Impact factor: 3.240

5.  Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway.

Authors:  Yurong Jiang; Tong Li; Yi Qian; Xiaoming Zuo; Jinmei Liu
Journal:  Pain Res Manag       Date:  2022-04-21       Impact factor: 2.667

6.  Impact of screening on cervical cancer incidence and mortality in a Northern Brazilian city.

Authors:  Lucrecia Aline Cabral Formigosa; Luciana Ferreira Dos Santos; Joana Dulce Cabral Formigosa; Denise da Silva Pinto; Danielle Saraiva Tuma Dos Reis; Marcos Valério Santos da Silva
Journal:  Ecancermedicalscience       Date:  2022-07-01

7.  Epidemiological Trends and Attributable Risk Burden of Cervical Cancer: An Observational Study from 1990 to 2019.

Authors:  Hu Yao; Chen Yan; He Qiumin; Zhou Li; Ai Jiao; Li Xin; Li Hong
Journal:  Int J Clin Pract       Date:  2022-09-30       Impact factor: 3.149

8.  Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia: Institutional-Based Retrospective Study.

Authors:  Mulugeta Wassie; Beletech Fentie; Tseganesh Asefa
Journal:  J Oncol       Date:  2021-06-17       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.